Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne muscular dystrophy (DMD)
Pharma
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
The incident brings attention to the safety of AAV-based gene therapies and could spark renewed concerns over the benefit-risk profile of Elevidys.
Angus Liu
Mar 18, 2025 10:34am
A heartwarming review of cardiovascular news, most-loved stories
Feb 14, 2025 9:00am
Sarepta's Elevidys blows sales expectations out of the water
Nov 7, 2024 3:43pm
FDA broadens label for Sarepta's Duchenne gene therapy Elevidys
Jun 21, 2024 7:51am
Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy
Mar 22, 2024 11:05am
PTC, after rejections, will try again with Translarna at the FDA
Mar 19, 2024 10:10am
